Shmunis Family Innovation Awards in Cancer Therapeutics

The Shmunis Family Innovation Awards in Cancer Therapeutics supports the bold and creative research of Stanford cancer researchers with award funding of $50,000-$100,000 per project to develop and test potential new therapeutic drug candidates that could lead to early phase clinical trials and transformative new treatments for patients.  This award was made possible by a generous gift from The So Inclined Philanthropic Foundation, the Family Foundation of Vlad and Sandra Shmunis.

Vlad and Sandra Shmunis are deeply committed to cancer research. Cancer is a disease that has unfortunately touched their family and far too many other families around the world. Their goal is to help make an impact by advancing research and bring new cancer therapies – and hope - to cancer patients and families.

Advancing new cancer treatments hinges on the success of a robust research and drug development program. Now more than ever, research and discovery are accelerating at a rapid pace. The SCI is focused on empowering researchers to pursue high-risk, high-reward drug development projects.  


RFA Announced: March 15, 2024
Notification of Selection: August 2024
Funding Period: October 1, 2024 – September 30, 2025

Vlad and Sandra Shmunis (Credit: Chen Galili)